365d
24h
60m
60s
Day 1: Investment Trends and Exit strategies
Capital is flowing into sectors positioned at the edge of what’s technically possible — AI, quantum, synthetic biology, climate tech, and next-gen healthcare. This block explores how investors are adapting their investment strategies. From global trends to sector-specific signals, this block equips investors to sharpen their perspective on where — and how — to deploy into tomorrow’s foundational technologies and adapt to the global changes.
Core Problem:
The global investment landscape is undergoing a profound shift — capital is flowing into sectors at the edge of technology, while family offices and institutional investors are facing increasing complexity in aligning legacy investment strategies with demands for sustainability, cross-border partnerships, and impact-driven outcomes. Successfully bridging the expectations gap between investors and startups, and building scalable exit pathways, is now critical.
​
Core Challenges:
-
How to navigate a global investment environment where Europe must compete with rapidly accelerating hubs in Asia and the Middle East.
-
How to integrate impact and ESG frameworks into long-term investment strategies without sacrificing returns.
-
How to build strategic industry partnerships early to improve biotech and healthcare exit outcomes (M&A, IPOs).
-
How to structure cross-border deals and collaborations in an increasingly fragmented global economy.
-
How family offices can grow their influence in direct investments while preserving governance and legacy values.
Key Topics Covered:
-
Comparative global investment trends (Europe, Switzerland, U.S., Asia).
-
Family offices' evolving role in direct investments and impact strategies.
-
How to align startups’ scaling needs with investors' expectations and risk models.
-
Building biotech exits through strategic partnerships with industry leaders.
-
Insights from founders and investors on successful cross-border exit strategies.
-
Investor reverse pitches sharing investment theses, exit strategies, and portfolio successes.
​
Detailed Activities:
Block 1: The Future of Venture & Family Office Investments
-
Keynote: Global Investment Trends: “Where is Capital Flowing?” Comparing Europe vs. other regions and How to combine impact investment as part of your investment strategy.
-
A comparative view: Europe vs. U.S. and Asia
-
Family offices: their growing influence in direct investments
-
Integrating impact and sustainability into a long-term investment strategy
-
-
Fireside Chat: Impact investment- How to change the paradigm with ESGs and ESG ratings.
-
Panel: “What Startups Need vs. What Investors Expect” — A candid conversation on alignment gaps.
-
Investor Pitch Session: Leading investors share current theses and open mandates (5 speakers)
​​
Block 2: Scaling Biotech: Building Strategic Partnerships for Global Growth
Industry role as major partner for Investor Strategies & Scaling Healthcare
​
-
Keynote: “The Art of Building Success in Biotech Partnerships: Industry-Driven M&A, Exits, and IPOs" Industry leaders will discuss strategic considerations behind successful biotech exits, including mergers, acquisitions, and public offerings . The session will explore how industry partnerships can enhance exit outcomes and drive sustainable growth. Speakers will share insights into navigating cross-border challenges, leveraging strategic alliances, and positioning companies for successful exits through IPOs or acquisitions. Attendees will gain a comprehensive understanding of how investors not only provide capital but also contribute industry expertise, networks, and strategic guidance to drive biotech success.
-
Panel: “Insights from Successful Founders and Investors” Founders and investors who have successfully exited biotech ventures will share their experiences, focusing on the importance of aligning with industry partners to achieve successful outcomes. The discussion will highlight key lessons learned and strategies employed to navigate the exit process effectively.​
-
Reverse Pitch: Investors will present their approaches to scaling biotech companies, emphasizing the role of strategic partnerships, cross-border deals, and engagement in emerging markets. They will discuss how these collaborations have led to successful exits and growth trajectories.
​
Networking:
Networking is structured around investment alignment — offering VCs and family offices access to vetted startups, peer investors, and emerging market insights.
​
Museum Tour and Cocktail Apero in Courtyard of Museum